Please login to the form below
Takecab
This page shows the latest Takecab news and features for those working in and with pharma, biotech and healthcare.
Biologics set to revolutionise the gastrointestinal market
Also contributing to the predicted market growth are recent product approvals such as Takeda's Takecab (vonoprazan) for gastroesophageal reflux disease, and Entvio (vedolizumab) for IBD.
Latest news
-
Rare disease therapies head the ‘class of 2015’
Baxalta. USA. vonoprazan fumarate. Takecab. acid-related diseases. potassium-competitive acid blocker. Takeda/Otsuka.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- UK pharmacies to begin administering COVID-19 vaccinations
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Research Partnership appoints Hannah Osborn to MedTech director role
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- NHS is set to begin offering COVID-19 vaccinations to over-70s this week
- Cambridge University develops DNA test for secondary infections in COVID-19 patients
- 2020 - a year to remember or forget?
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Quick links
Infographics
